The North America Bioprocess Bags Market should witness market growth of 15.0% CAGR during the forecast period (2023-2029).
Depending on the uses and range of capacities, single-layer, and multilayer biocontainers are available. Additionally, for the biopharmaceutical industry, quality, control, and consistency are vitally crucial. The same applies to the one-time-use bioprocessing bags created to manufacture biopharmaceutical products.
Single-use bioprocessing bags and liners are manufactured to prepare, store, and transport intermediates, biopharmaceutical liquids, and final bulk products. Single-use systems, which are utilized in the production of biopharmaceuticals, increase process safety by lowering the possibility of cross-contamination between batches and products.
Operations that are costly and time-consuming are minimized. As a result, not only does the entire manufacturing process see significant cost reductions, but capacity utilization is also optimized. Equipment for single-use bioprocessing has quickly gained widespread acceptance. Disposable products and parts have carved out new market niches and market segments that are still developing.
Approximately one-third of the biopharmaceutical industry is accounted for by the United States, which also leads the world in biopharmaceutical research and development. The biopharmaceutical companies invested $97 billion in R&D in the United States in 2017, and the biopharmaceutical industry has a substantial total economic impact on the US economy. In 2018, companies with large foreign ownership that operate in the United States exported biopharmaceuticals worth over $17 billion.
In addition, these primarily foreign-owned companies invested nearly $20 billion in R&D in the same year. In 2019, $511.3 billion in foreign direct investment was made in the pharmaceutical and medical industries. Hence, with the robust biopharma and pharma industry in the region with a significant investment in R&D projects to meet the strict regulatory standards, the utilization and development of bioprocess bags are expected to surge during the manufacturing and storing processes, aiding the market growth in North America.
The US market dominated the North America Bioprocess Bags Market by Country in 2022, thereby, achieving a market value of $1,886.1 million by 2029. The Canada market is registering a CAGR of 17.7% during (2023-2029). Additionally, The Mexico market would showcase a CAGR of 16.6% during (2023-2029).
Based on Workflow, the market is segmented into Upstream Process, Downstream Process and Process Development. Based on Type, the market is segmented into 2D, 3D and Others. Based on End-User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs and Academic & Research Institutes. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Sartorius AG, Danaher Corporation, Saint-Gobain Group, Corning Incorporated, Meissner Filtration Products, Inc., Merck KGaA, Entegris, Inc., PROAnalytics, LLC, and CellBios Healthcare and Lifesciences Pvt Ltd.
Depending on the uses and range of capacities, single-layer, and multilayer biocontainers are available. Additionally, for the biopharmaceutical industry, quality, control, and consistency are vitally crucial. The same applies to the one-time-use bioprocessing bags created to manufacture biopharmaceutical products.
Single-use bioprocessing bags and liners are manufactured to prepare, store, and transport intermediates, biopharmaceutical liquids, and final bulk products. Single-use systems, which are utilized in the production of biopharmaceuticals, increase process safety by lowering the possibility of cross-contamination between batches and products.
Operations that are costly and time-consuming are minimized. As a result, not only does the entire manufacturing process see significant cost reductions, but capacity utilization is also optimized. Equipment for single-use bioprocessing has quickly gained widespread acceptance. Disposable products and parts have carved out new market niches and market segments that are still developing.
Approximately one-third of the biopharmaceutical industry is accounted for by the United States, which also leads the world in biopharmaceutical research and development. The biopharmaceutical companies invested $97 billion in R&D in the United States in 2017, and the biopharmaceutical industry has a substantial total economic impact on the US economy. In 2018, companies with large foreign ownership that operate in the United States exported biopharmaceuticals worth over $17 billion.
In addition, these primarily foreign-owned companies invested nearly $20 billion in R&D in the same year. In 2019, $511.3 billion in foreign direct investment was made in the pharmaceutical and medical industries. Hence, with the robust biopharma and pharma industry in the region with a significant investment in R&D projects to meet the strict regulatory standards, the utilization and development of bioprocess bags are expected to surge during the manufacturing and storing processes, aiding the market growth in North America.
The US market dominated the North America Bioprocess Bags Market by Country in 2022, thereby, achieving a market value of $1,886.1 million by 2029. The Canada market is registering a CAGR of 17.7% during (2023-2029). Additionally, The Mexico market would showcase a CAGR of 16.6% during (2023-2029).
Based on Workflow, the market is segmented into Upstream Process, Downstream Process and Process Development. Based on Type, the market is segmented into 2D, 3D and Others. Based on End-User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs and Academic & Research Institutes. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Sartorius AG, Danaher Corporation, Saint-Gobain Group, Corning Incorporated, Meissner Filtration Products, Inc., Merck KGaA, Entegris, Inc., PROAnalytics, LLC, and CellBios Healthcare and Lifesciences Pvt Ltd.
Scope of the Study
By Workflow
- Upstream Process
- Downstream Process
- Process Development
By Type
- 2D
- 3D
- Others
By End-User
- Pharmaceutical & Biopharmaceutical Companies
- CMOs & CROs
- Academic & Research Institutes
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Danaher Corporation
- Saint-Gobain Group
- Corning Incorporated
- Meissner Filtration Products, Inc.
- Merck KGaA
- Entegris, Inc.
- PROAnalytics, LLC
- CellBios Healthcare and Lifesciences Pvt Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Bioprocess Bags Market by Workflow
Chapter 4. North America Bioprocess Bags Market by Type
Chapter 5. North America Bioprocess Bags Market by End-User
Chapter 6. North America Bioprocess Bags Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Danaher Corporation
- Saint-Gobain Group
- Corning Incorporated
- Meissner Filtration Products, Inc.
- Merck KGaA
- Entegris, Inc.
- PROAnalytics, LLC
- CellBios Healthcare and Lifesciences Pvt Ltd.
Methodology
LOADING...
